News
-
-
PRESS RELEASE
Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time
Monogram Technologies Inc. to host conference call webcast on May 14, 2025, discussing Q1 financial results, FDA 510(k) Clearance for mBôs TKA System, and upcoming clinical trials in India -
-
PRESS RELEASE
Trans Canada Gold Corp. Ships 3,919 Barrels for the Month of April 2025, From its Lloydminster Multilateral Heavy Oil Well and Prepares for the Summer Mulitlateral Drilling Program
Trans Canada Gold Corp announces completion of another month of steady oil production for April 2025 and plans to commence drilling a multi-lateral well targeting Sparky formation in summer 2025 -
-
-
-
-
PRESS RELEASE
Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
Tharimmune, Inc. presents promising pharmacokinetic and metabolism data of TH104, a buccal film of nalmefene, for prophylaxis against opioid exposure. Study results showcased at Digestive Disease Week 2025 -
PRESS RELEASE
Galimedix Therapeutics completes single ascending dose part of Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator
Galimedix Therapeutics completes single ascending dose of Phase 1 study with oral small molecule GAL-101 targeting amyloid beta aggregation modulator, supporting oral administration route. Next study arms and indications revealed
